
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell RNA sequencing dataset of breast cancer tissue, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **ATP Synthase Complex Subunits (ATP5E, ATP5L, ATP5I, ATP5D, ATP5G1, ATP5G2, ATP5G3, ATP5J, ATP5J2, ATP5H, ATP5O, ATP5B, ATP5A1, ATP5C1, ATP5F1):** These genes encode subunits of the ATP synthase complex, which is crucial for ATP production in mitochondria. High expression of these genes suggests a high metabolic activity, often seen in cells with high energy demands.<br>- **COL1A1, COL1A2, COL3A1:** These genes encode collagen proteins, which are structural components of the extracellular matrix. Their expression is typically associated with fibroblasts and cells involved in tissue remodeling and repair.<br>- **SEPP1, SELM, SEP15, SELK:** These genes are involved in selenium metabolism and antioxidant defense, which can be important in protecting cells from oxidative stress.<br>- **DCN (Decorin):** A small leucine-rich proteoglycan involved in collagen fibrillogenesis and modulation of cell growth. It is often expressed in fibroblasts and stromal cells.<br><br>### Step 2: List the Key Cell Type Markers<br>- **CD248 (Endosialin):** A marker often associated with pericytes and stromal cells, particularly in the tumor microenvironment.<br>- **SFRP2 (Secreted Frizzled-Related Protein 2):** Involved in Wnt signaling modulation, often expressed in mesenchymal and stromal cells.<br>- **IGFBP4 (Insulin-like Growth Factor Binding Protein 4):** Modulates IGF signaling, commonly expressed in stromal and mesenchymal cells.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, the expression of these markers is consistent with cells involved in the extracellular matrix and stromal components, particularly fibroblasts and related mesenchymal cells.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of collagen genes (COL1A1, COL1A2, COL3A1), ATP synthase subunits, and markers like CD248 and DCN, the most probable general cell type is **fibroblasts** or **stromal cells**. These cells are known for their role in producing extracellular matrix components and supporting tissue structure.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Cancer-associated fibroblasts (CAFs):** Given the context of breast cancer tissue, these fibroblasts are likely involved in tumor progression and remodeling of the tumor microenvironment.<br>2. **Myofibroblasts:** A subtype of fibroblasts characterized by the expression of contractile proteins and involvement in wound healing and fibrosis.<br>3. **Pericytes:** While less likely, the presence of CD248 suggests a potential role in vascular support and interaction with endothelial cells.<br><br>The most likely subtype, given the context and marker expression, is **cancer-associated fibroblasts (CAFs)**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is primarily composed of fibroblasts, specifically cancer-associated fibroblasts (CAFs). This conclusion is supported by the high expression of collagen genes, ATP synthase subunits, and markers like CD248 and DCN, which are characteristic of fibroblasts and stromal cells involved in the tumor microenvironment.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency:**<br>   - The markers used in the annotation (e.g., ATP synthase complex subunits, COL1A1, COL1A2, COL3A1, SEPP1, SELM, SEP15, SELK, DCN, CD248, SFRP2, IGFBP4) are present in the provided marker list.<br>   - The expression of these markers is consistent with fibroblasts and stromal cells, particularly in the context of breast cancer tissue.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The annotation considers the possibility of mixed cell types by identifying potential subtypes such as cancer-associated fibroblasts (CAFs), myofibroblasts, and pericytes.<br>   - The presence of markers like CD248 and SFRP2 supports the identification of stromal and mesenchymal cells, which aligns with the annotation of fibroblasts and related subtypes.<br><br>The analysis correctly identifies the cell cluster as primarily composed of fibroblasts, specifically cancer-associated fibroblasts (CAFs), based on the expression of key markers. The annotation is well-supported by the marker list and the context of breast cancer tissue.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">fibroblasts</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>cancer-associated fibroblasts (CAFs)</li><li>myofibroblasts</li><li>pericytes</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a strong understanding of the single-cell RNA sequencing data from breast cancer tissue. The analysis correctly identifies the main cell type as fibroblasts, specifically cancer-associated fibroblasts (CAFs), which is consistent with the expression of key markers such as collagen genes (COL1A1, COL1A2, COL3A1) and ATP synthase subunits. These markers are indeed indicative of fibroblasts and stromal cells, particularly in the context of a tumor microenvironment.<br><br>The annotation process shows a balanced consideration of multiple markers, rather than over-focusing on a specific one. For instance, the inclusion of markers like CD248 and SFRP2 supports the identification of stromal and mesenchymal cells, which aligns with the annotation of fibroblasts and related subtypes. This demonstrates a comprehensive approach to understanding the cell populations present.<br><br>The analysis also considers the possibility of mixed cell types by identifying potential subtypes such as myofibroblasts and pericytes. This indicates an awareness of the complexity and heterogeneity of the tumor microenvironment, which is a strength of the annotation.<br><br>However, one potential area for improvement is the consideration of the rank of the markers. While the analysis does a good job of identifying key markers, it could place more emphasis on the markers that appear first in the list, as these are likely more important. Additionally, while the annotation is well-supported by the marker list and context, it could benefit from a more explicit discussion of how the rank of the markers influenced the final annotation.<br><br>Overall, the annotation is scientifically accurate, well-balanced, and provides a comprehensive view of the cell types present. There are no obvious misclassifications or oversights, and the analysis captures the general picture of the cell populations effectively.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    